Business

The Readout Meghana Keshavan

STAT Plus: The biotech news you need to start the week

Exclusive Bob Herman

STAT Plus: Amazon cuts ties with fertility benefits company Progyny

The Readout Meghana Keshavan

STAT Plus: Are generalist investors good or bad for biotech?

Exclusive John Wilkerson

STAT Plus: Cassidy seeks to exempt small biotechs from Medicare drug price negotiation 

Business Aaron Pressman — Boston Globe

STAT Plus: Senate panel votes to hold Steward Health Care CEO in contempt

The Readout Elaine Chen

STAT Plus: The Fed cut rates and biotech stocks… didn’t do much

Health tech Lizzy Lawrence

STAT Plus: FDA designates devices for heart surgery, smart knee implant as ‘breakthroughs’

Politics Mario Aguilar and Rachel Cohrs Zhang

STAT Plus: House panel advances bill to extend Medicare’s telehealth flexibilities, setting up December talks

Exclusive Bob Herman

STAT Plus: Hospital giant Ascension recorded about $1.3 billion in losses from its cyberattack

The Readout Elaine Chen

STAT Plus: Bernie Sanders keeps the heat on Novo’s high prices

The Readout Elaine Chen

STAT Plus: FDA formalizes protocol for international cancer trials

Health Care Inc. Bob Herman

STAT Plus: How insurers are covering Humira and copycat medicines

The Readout Meghana Keshavan

STAT Plus: The essential biotech updates of the day

Biotech Jonathan Wosen

STAT Plus: Exact Sciences reports initial positive results in colon cancer blood test, but pivot trial still pending

The Readout Elaine Chen

STAT Plus: Can GLP-1 drugs help with type 1 diabetes?

Insurance Tara Bannow

STAT Plus: Insurers went all-in on Medicare Advantage. Now, some are scaling back 

The Readout Elaine Chen

STAT Plus: Moderna cuts spending, and Sarepta’s ‘curse’ on Califf

Business Mario Aguilar and Timmy Broderick

STAT Plus: Apple will offer millions of AirPod users a hearing aid. Can it convince them to use it?

The Readout Meghana Keshavan

STAT Plus: Eli Lilly releases new data on weekly insulin

Insurance Bob Herman

STAT Plus: Elevance buys IU Health’s insurance company

Politics Nicholas Florko

STAT Plus: Key lawmakers are wary of giving FDA more cash to crack down on e-cigs

The Readout Meghana Keshavan

STAT Plus: Five biotech news stories you need to read today

Health Care Inc. Bob Herman

STAT Plus: How powerful hospitals helped take R1 RCM private

The Readout Meghana Keshavan

STAT Plus: Terns’ GLP-1 pill leads to weight loss in early study

Health tech Mario Aguilar

STAT Plus: Highmark reboots coverage of digital treatments, raising hope among DTx companies

Biotech Matthew Herper

STAT Plus: With a win in lung cancer, biotech’s wealthiest outsider surfs to new heights

Hospitals Bob Herman

STAT Plus: Ascension, other hospitals played active roles to take medical billing company R1 RCM private

The Readout Meghana Keshavan

STAT Plus: Lilly has more positive data on its weekly insulin

The Readout Elaine Chen

STAT Plus: BioMarin’s big day today